Advancing the World of Health

The company was founded in 1897 in New York City by Maxwell Becton and Fairleigh S. Dickinson. We know that possibilities are endless when people feel supported and inspired. At BD, we believe that people are at the heart of every breakthrough, solution, and step forward.

Quality Engineer jobs

BD can help you optimize clinical effectiveness to help drive improvement in patient outcomes Quality standards, cost controls and efficiency

Quality Engineer jobs

Designed and validated for use with cell suspensions, whole blood and tissue pieces. BD Horizon RealViolet™ 544 Reagents offer limited spillover, robust intracellular performance and lot-to-lot consistency. In December 2025, BD was sued by Tela Bio Inc., makers of a ovine forestomach matrix hernia mesh, who alleged that BD engaged in anticompetitive practices to push Tela out of the market for surgical meshes while raising prices for providers and patients.

This agreement protects patents and intellectual properties of both companies ensuring the quality and integrity of Embecta Corporation’s cannulas used in their products. The transaction was completed later that year, and the company became a wholly-owned subsidiary of BD, rebranded as Bard. In October 2014, the company agreed to acquire CareFusion for a price of US$12.2 billion in cash and stock. Later Retractable would claim BD was falsely advertising its own brand of retractable needle as the “world’s sharpest needle”. Retractable would accuse BD of patent infringement after BD released a retractable needle of its own. The lawsuit touched off a series of legal conflicts between the companies.

The company supports those on the frontlines of healthcare by developing transformative technologies, services and solutions that optimize clinical operations and improve care for patients. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase clinical efficiency, improve safety and expand access to healthcare. Quality of care, cost efficiency, healthcare worker and patient safety and experience Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare. Bard, Inc. and its parent company BD were fined $60 million USD for failing to adequately inform patients about health risks related to their transvaginal mesh devices.

Q-Syte Luer and IV Catheter partial recall

• The company supports those on the frontlines of healthcare by developing transformative technologies, services and solutions that optimize clinical operations and improve care for patients.
• Bard, Inc. and its parent company BD were fined $60 million USD for failing to adequately inform patients about health risks related to their transvaginal mesh devices.
• Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare.
• Our Purpose drives us to create innovative solutions that make a meaningful impact on advancing the world of health™.

The approximately 2.8 million BD Q-Syte and 2.9 million BD Nexiva units containing 5 million BD Q-Syte devices that were recalled were distributed in the United States, Asia, Canada, Europe, Mexico, the Middle East, South Africa, and South America. BD recalled and tested the syringes in question, and revealed sterile particulates in 0.013 percent of the products. They found repeat and serious violations of health and safety law that had resulted in two employees having partial finger amputations. Embecta Corporation is a standalone public company focused on diabetes care.

BD can help you identify potential “at-risk” patients, empower clinical intervention, and advance health system insights A unique ecosystem to collaborate on flow cytometry panel design, improve cytometer efficiency and manage your laboratory. An interactive tool containing key cell information to help plan your flow cytometry experiments. The BD Rhapsody™ single-cell platform has been a key tool for the publication of our clinical research. Food and Drug Administration chickenroadonline-bd.com/ and worldwide health agencies to coordinate recall activities.